TARDBP and proteostasis deficiencies: Thus, a complementary strategy to model TDP-43 pathology is to remove WT TDP-43 from the nucleus by different approaches, including different stress treatments or by mutating genes/pathways involved in TDP-43 proteinopathies other than TDP-43 itself.